Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate

Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate

Ductal adenocarcinoma of the prostate is a rare histological variant that only represents <1% of prostate tumors. This histological variant has several important clinical implications with respect to their evolution, clinical prognosis, and treatment. We report the case of a 64-year-old patient w...

Full description

Bibliographic Details
Main Authors: Linden-Castro, Edgar, Pelayo-Nieto, Marcela, Alias-Melgar, Alejandro, Espinosa-Perezgrovas, Daniel, Ramirez-Galindo, Ivan, Catalan-Quinto, Gabriel
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033549/
id pubmed-4033549
recordtype oai_dc
spelling pubmed-40335492014-06-02 Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate Linden-Castro, Edgar Pelayo-Nieto, Marcela Alias-Melgar, Alejandro Espinosa-Perezgrovas, Daniel Ramirez-Galindo, Ivan Catalan-Quinto, Gabriel Case Report Ductal adenocarcinoma of the prostate is a rare histological variant that only represents <1% of prostate tumors. This histological variant has several important clinical implications with respect to their evolution, clinical prognosis, and treatment. We report the case of a 64-year-old patient with ductal adenocarcinoma of the prostate, which progresses to castration-resistant prostate cancer, that was treated with abiraterone acetate with good clinical response, to our knowledge, the first case of ductal adenocarcinoma of the prostate in treatment with abiraterone acetate. Hindawi Publishing Corporation 2014 2014-05-07 /pmc/articles/PMC4033549/ /pubmed/24891969 http://dx.doi.org/10.1155/2014/508305 Text en Copyright © 2014 Edgar Linden-Castro et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Linden-Castro, Edgar
Pelayo-Nieto, Marcela
Alias-Melgar, Alejandro
Espinosa-Perezgrovas, Daniel
Ramirez-Galindo, Ivan
Catalan-Quinto, Gabriel
spellingShingle Linden-Castro, Edgar
Pelayo-Nieto, Marcela
Alias-Melgar, Alejandro
Espinosa-Perezgrovas, Daniel
Ramirez-Galindo, Ivan
Catalan-Quinto, Gabriel
Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
author_facet Linden-Castro, Edgar
Pelayo-Nieto, Marcela
Alias-Melgar, Alejandro
Espinosa-Perezgrovas, Daniel
Ramirez-Galindo, Ivan
Catalan-Quinto, Gabriel
author_sort Linden-Castro, Edgar
title Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
title_short Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
title_full Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
title_fullStr Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
title_full_unstemmed Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
title_sort abiraterone acetate and castration resistant ductal adenocarcinoma of the prostate
description Ductal adenocarcinoma of the prostate is a rare histological variant that only represents <1% of prostate tumors. This histological variant has several important clinical implications with respect to their evolution, clinical prognosis, and treatment. We report the case of a 64-year-old patient with ductal adenocarcinoma of the prostate, which progresses to castration-resistant prostate cancer, that was treated with abiraterone acetate with good clinical response, to our knowledge, the first case of ductal adenocarcinoma of the prostate in treatment with abiraterone acetate.
publisher Hindawi Publishing Corporation
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033549/
_version_ 1612093242427310080

Similar Items